SCHEMBL5344906

SCHEMBL5344906

COC(=O)C1C(O)C(=O)OC1(C)C

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 4/20 0.32
GAA P10253 2/20 0.32
LMNA P02545 1/20 0.32
HSD17B10 Q99714 1/20 0.32
IDO1 P14902 1/20 0.32
CYP3A4 P08684 2/20 0.32
MEN1 O00255 1/20 0.32
CYP2D6 P10635 1/20 0.32
ALOX15 P16050 1/20 0.32
CYP2C19 P33261 1/20 0.32
CYP1A2 P05177 1/20 0.31
HIF1A Q16665 1/20 0.31
CYP2C9 P11712 1/20 0.31
CCR6 P51684 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4611550 0.81 ALDH1A1 (0.49) ALDH1A1GAALMNAHTT
SCHEMBL5192114 0.77 CYP3A4 (0.30) CYP3A4CYP2C9
SCHEMBL6654546 0.75 ALDH1A1 (0.54) KMT2AALDH1A1GAAMEN1CYP1A2
SCHEMBL4612385 0.67 IDO1 (0.33) IDO1
SCHEMBL2690897 0.65 HTT (0.35) ELANEKMT2AALDH1A1GAALMNA
SCHEMBL2690901 0.65 HTT (0.35) ELANEKMT2AALDH1A1GAALMNA
SCHEMBL2690895 0.65 HTT (0.35) ELANEKMT2AALDH1A1GAALMNA
SCHEMBL20253604 0.64 KMT2A (0.33) ELANEKMT2AALDH1A1CYP1A2HIF1A
SCHEMBL5350470 0.64 HTT (0.34) ELANEKMT2AALDH1A1GAALMNA
SCHEMBL27575442 0.64 BACE1 (0.38) IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271297-B2 Process for producing vinyl ether compounds DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2007-09-18 US disclosed
US-7183423-B1 Process for the preparation of organic compounds with imide catalysts DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2007-02-27 US disclosed
US-20060205957-A1 Process for producing vinyl ether compounds ISHII YASUTAKA 2006-09-14 US disclosed
US-7074970-B2 Process for producing vinyl ether compounds DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2006-07-11 US disclosed
EP-1288186-A2 Vinyl ether compounds and preparation process thereof Daicel Chemical Industries, Ltd. (JP) 2003-03-05 EP disclosed
EP-1055654-A1 PROCESS FOR THE PREPARATION OF ORGANIC COMPOUNDS WITH IMIDE CATALYSTS Daicel Chemical Industries, Ltd. (JP) 2000-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060205957-A1 Process for producing vinyl ether compounds ETV6, CYP3A4, SUV39H2 ELANE 3521/4885KMT2A 806/4885ALDH1A1 1064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.